BIO-SCALE Act
The BIO-SCALE Act establishes a program to build at least three regional, nonprofit facilities designed to help bioindustrial companies test and scale up new technologies for producing chemicals, fuels, and materials. Funded by approximately $462 million over ten years, these open-access sites will provide large-scale equipment for public and private organizations to move innovations from the lab to commercial production without intellectual property barriers. The Department of Commerce will select facility locations through a competitive process that prioritizes areas near raw material sources and regions with existing biotech industries to promote economic growth and national security.
Bill status
in committee
1 of 4 stages cleared
Introduction
May 2026
Committee Review
Floor Vote
President
Introduced May 20, 2026
Last action May 20, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
May 20, 2026
Committee
Referred to the Committee on Transportation and Infrastructure, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
May 20, 2026
Introduced
Introduced in House
lower
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 8918
Scope: US
Hi! I can help you understand HR 8918. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline